Chronic Total Occlusion

Top Story

CTO PCI similar to medical therapy in CV death, MI risk at 3 years: EURO-CTO

CTO PCI similar to medical therapy in CV death, MI risk at 3 years: EURO-CTO
October 3, 2019
5 Questions with Dr. Bhatt

A Conversation With Emmanouil S. Brilakis, MD, PhD, FSCAI

Cardiology Today's Intervention, May/June 2019
For this issue, Dr. Bhatt talks with Cardiology Today’s Intervention Editorial Board Member Emmanouil S. Brilakis, MD, PhD, FSCAI, director of the Center for…
CTO Corner

Hiking and CTO PCI: Lessons Learned

Cardiology Today's Intervention, March/April 2019
Emmanouil S. Brilakis, MD, PhD
One might not think there are many similarities between hiking and chronic total occlusion PCI, but a recent family trip led me to think there are many lessons about…
FDA News

FDA approves stent platform to treat chronic total occlusions

February 26, 2019
Medtronic announced today that the FDA has approved its drug-eluting stent platform for treatment of de novo chronic total occlusion lesions in patients with CAD. The…
More Headlines »
Cath Lab Techniques

Wanted: A Hybrid Peripheral CTO Algorithm

Cardiology Today's Intervention, September/October 2017
J.A. Mustapha, MD, FACC, FSCAI
The comparison of peripheral chronic total occlusions and coronary CTOs is like comparing apples to oranges. There are…
More »
Meeting News Coverage

VIDEO: Results from 'foundational' study indicate influence of CTO PCI on depression

November 11, 2015
More »
In the Journals

Bivalirudin, heparin equally effective in elderly patients undergoing CTO PCI

February 15, 2019
Among elderly patients at high bleeding risk undergoing PCI for chronic total occlusion, bivalirudin was as safe and…
More »